Electrophysiological effects of neuropeptide S on rat ventromedial hypothalamic neurons in vitro. 2010

Keitaro Yoshida, and Juhyon Kim, and Kazuki Nakajima, and Yutaka Oomura, and Matthew J Wayner, and Kazuo Sasaki
Division of Bio-Information Engineering, Faculty of Engineering, University of Toyama, 3190 Gofuku, Toyama 930-8555, Japan.

The newly identified neuropeptide S (NPS) is a ligand for a previously orphan G protein-coupled GPR 154 receptor, now named the NPS receptor (NPSR). Previous studies have shown that NPS induces hyperlocomotion, increases arousal and suppresses anxiety-like behaviors via NPSR. Although NPS also inhibits food intake, nothing is known about the neuronal mechanisms underlying this action. Anatomical studies show that NPSRs are expressed abundantly in the dorsomedial part of the ventromedial hypothalamic nucleus (VMH), a satiety center for food intake. Hence, we examined the electrophysiological effects of NPS on rat VMH neurons in vitro. NPS predominantly depolarized the VMH neurons, and the effects were postsynaptic and dose-dependent. Membrane resistance was significantly decreased during the depolarization, suggesting an opening of some ionic channels. The NPS-induced depolarization was significantly attenuated in Ca(2+)-free, NiCl(2)-containing and mibefradil-containing TTX ACSFs, but it did not disappear. The NPS-induced depolarization was also attenuated in low-Na(+) TTX ACSF, and completely abolished in Ca(2+)-free/low-Na(+) TTX ACSF. Pretreatment with 30 microM KB-R7943, an inhibitor of forward-mode Na(+)/Ca(2+) exchanger, did not have any significant effect on the NPS-induced depolarization in Ca(2+)-free TTX ACSF. These results suggest that NPS depolarizes VMH neurons via activations of R- and T-type Ca(2+) channels and nonselective cation channels, and that VMH neurons might be involved in the cellular process through which NPS participates in the regulation of food intake and energy homeostasis.

UI MeSH Term Description Entries
D008297 Male Males
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D009532 Nickel A trace element with the atomic symbol Ni, atomic number 28, and atomic weight 58.69. It is a cofactor of the enzyme UREASE.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23
D013779 Tetrodotoxin An aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the order TETRAODONTIFORMES, which are eaten. The toxin causes paresthesia and paralysis through interference with neuromuscular conduction. Fugu Toxin,Tarichatoxin,Tetradotoxin,Toxin, Fugu

Related Publications

Keitaro Yoshida, and Juhyon Kim, and Kazuki Nakajima, and Yutaka Oomura, and Matthew J Wayner, and Kazuo Sasaki
October 2008, Endocrinology,
Keitaro Yoshida, and Juhyon Kim, and Kazuki Nakajima, and Yutaka Oomura, and Matthew J Wayner, and Kazuo Sasaki
January 1982, Brain research,
Keitaro Yoshida, and Juhyon Kim, and Kazuki Nakajima, and Yutaka Oomura, and Matthew J Wayner, and Kazuo Sasaki
June 1997, The American journal of physiology,
Keitaro Yoshida, and Juhyon Kim, and Kazuki Nakajima, and Yutaka Oomura, and Matthew J Wayner, and Kazuo Sasaki
June 2010, Peptides,
Keitaro Yoshida, and Juhyon Kim, and Kazuki Nakajima, and Yutaka Oomura, and Matthew J Wayner, and Kazuo Sasaki
July 2016, Steroids,
Keitaro Yoshida, and Juhyon Kim, and Kazuki Nakajima, and Yutaka Oomura, and Matthew J Wayner, and Kazuo Sasaki
January 1986, Physiology & behavior,
Keitaro Yoshida, and Juhyon Kim, and Kazuki Nakajima, and Yutaka Oomura, and Matthew J Wayner, and Kazuo Sasaki
March 1976, Physiology & behavior,
Keitaro Yoshida, and Juhyon Kim, and Kazuki Nakajima, and Yutaka Oomura, and Matthew J Wayner, and Kazuo Sasaki
March 2010, Neurotoxicology,
Keitaro Yoshida, and Juhyon Kim, and Kazuki Nakajima, and Yutaka Oomura, and Matthew J Wayner, and Kazuo Sasaki
January 2013, PloS one,
Keitaro Yoshida, and Juhyon Kim, and Kazuki Nakajima, and Yutaka Oomura, and Matthew J Wayner, and Kazuo Sasaki
March 1988, Brain research,
Copied contents to your clipboard!